Yukon Kuskokwim Health Corporation
8
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
13%
1 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People
Role: collaborator
YK Delta Food Box Study
Role: collaborator
Efficacy-Implementation Study for PC CARES in Rural Alaska
Role: collaborator
Back to Basics: Addressing Childhood Obesity Through Traditional Foods in Alaska
Role: collaborator
Community Intervention to Reduce Tobacco Use in Pregnant Women
Role: collaborator
Employee Wellness Survey
Role: collaborator
Tobacco Cessation Treatment for Alaska Native Youth
Role: collaborator
Study to Eliminate Hib Carriage in Rural Alaska Native Villages
Role: collaborator
All 8 trials loaded